{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:49:08Z","timestamp":1791132548803,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1614,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Chronic hepatitis B virus (HBV) infection is a major etiologic factor in hepatocellular carcinoma (HCC) pathogenesis, involving effects of chronic liver inflammation and of the weakly oncogenic HBV X protein (pX). pX-mediated hepatocyte transformation requires Polo-like kinase1 (Plk1) activity, but the mechanism is not fully understood. We identified by a genome-wide short hairpin RNA (shRNA) library screen the genes zinc finger, MYM-type 2 (ZNF198) and suppressor of zeste 12 homolog (<\/jats:bold>\n                                 <jats:bold>\n                                    Drosophila)\n                                 <\/jats:bold>\n                                 <jats:bold>(SUZ12) whose protein depletion rescues pX-expressing cells from DNA damage-induced apoptosis. ZNF198 and SUZ12 are components of chromatin remodeling complexes and associate with promyelocytic leukemia (PML) nuclear bodies. Knockdown of ZNF198 and SUZ12 by small interfering RNA (siRNA) reduced p53 stability and DNA repair, rescued pX-expressing hepatocytes from DNA damage-induced apoptosis, and increased pX-induced polyploidy and oncogenic transformation, suggesting ZNF198 and SUZ12 have a role in pX-mediated transformation. Interestingly, during pX-mediated transformation the protein but not messenger RNA (mRNA) levels of ZNF198 and SUZ12 progressively decreased, whereas Plk1 levels increased. Inhibition of Plk1 activity restored protein levels of ZNF198 and SUZ12. In addition, transfected Polo-box-domain (PBD) of Plk1 coimmunoprecipitated with ZNF198 and SUZ12, suggesting that these proteins are Plk1 substrates. Elevated Plk1 and reduced protein levels of ZNF198 and SUZ12 were also observed in human liver cancer cell lines derived from HBV-related tumors and in the presence of HBV replication. Importantly, knockdown by siRNA of ZNF198 and SUZ12 enhanced HBV replication.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>Reduced protein levels of ZNF198 and SUZ12 and elevated Plk1 occur during pX-mediated hepatocyte transformation in human liver cancer cell lines, as well as during HBV replication, underscoring the significance of these genes both in HBV-mediated HCC pathogenesis and HBV replication. We propose Plk1 activity down-regulates ZNF198 and SUZ12, thereby enhancing both HBV replication and pX-mediated oncogenic transformation. (HEPATOLOGY 2011)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.24163","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T18:07:47Z","timestamp":1294682867000},"page":"1137-1147","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":53,"title":["Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication"],"prefix":"10.1097","volume":"53","author":[{"given":"Wen-Horng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo L.","family":"Studach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania M.","family":"Andrisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20241104","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"R2-9-20241104","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0300-483X(02)00253-6","article-title":"Molecular pathogenesis of human hepatocellular carcinoma.","volume":"181182","author":"Wang","year":"2002","journal-title":"Toxicology"},{"key":"R3-9-20241104","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2893.2005.00712.x","article-title":"A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.","volume":"13","author":"Zoulim","year":"2006","journal-title":"J Viral Hepatitis"},{"key":"R4-9-20241104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R5-9-20241104","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.1073\/pnas.91.26.12808","article-title":"Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.","volume":"91","author":"Hagen","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-9-20241104","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.onc.1200850","article-title":"The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.","volume":"14","author":"Terradillos","year":"1997","journal-title":"Oncogene"},{"key":"R7-9-20241104","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.75.8.3851-3858.2001","article-title":"Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.","volume":"75","author":"Madden","year":"2001","journal-title":"J Virol"},{"key":"R8-9-20241104","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.510270428","article-title":"Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas.","volume":"27","author":"Su","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R9-9-20241104","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/jvi.68.3.2026-2030.1994","article-title":"Woodchuck hepatitis virus X protein is required for viral infection in vivo.","volume":"68","author":"Zoulim","year":"1994","journal-title":"J Virol"},{"key":"R10-9-20241104","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","article-title":"The enigmatic X gene of hepatitis B virus.","volume":"78","author":"Bouchard","year":"2004","journal-title":"J Virol"},{"key":"R11-9-20241104","first-page":"373","article-title":"The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis.","volume":"15","author":"Andrisani","year":"1999","journal-title":"Int J Oncol"},{"key":"R12-9-20241104","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1074\/jbc.M108025200","article-title":"Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus non-transforming hepatocyte (AML12) cell lines.","volume":"277","author":"Lee","year":"2002","journal-title":"J Biol Chem"},{"key":"R13-9-20241104","doi-asserted-by":"crossref","first-page":"28729","DOI":"10.1074\/jbc.M802751200","article-title":"Hepatitis B virus X protein increases the Cdt1 to geminin ratio inducing DNA re-replication and polyploidy.","volume":"283","author":"Rakotomalala","year":"2008","journal-title":"J Biol Chem"},{"key":"R14-9-20241104","doi-asserted-by":"crossref","first-page":"30282","DOI":"10.1074\/jbc.M109.093963","article-title":"Hepatitis B Virus X protein activates Polo-like Kinase-1 inducing checkpoint adaptation, suppression of DNA repair and p53 apoptosis.","volume":"285","author":"Studach","year":"2010","journal-title":"J Biol Chem"},{"key":"R15-9-20241104","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.22996","article-title":"Polo-like kinase1 inhibition suppresses Hepatitis B virus X protein-induced transformation, in an in vitro model of liver cancer progression.","volume":"50","author":"Studach","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R16-9-20241104","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ceb.2008.10.005","article-title":"Pentronczki. Polo-like kinase1 reaches beyond mitosis-cytokenisis, DNA damage response and development.","volume":"20","author":"Takaki","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"R17-9-20241104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.onc.1208272","article-title":"Polo-like kinases (Plks) and cancer.","volume":"24","author":"Takai","year":"2005","journal-title":"Oncogene"},{"key":"R18-9-20241104","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","article-title":"Gene expression patterns in human liver cancers.","volume":"13","author":"Chen","year":"2002","journal-title":"Mol Biol Cell"},{"key":"R19-9-20241104","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/sj.onc.1209276","article-title":"Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16E6.","volume":"25","author":"Incassati","year":"2006","journal-title":"Oncogene"},{"key":"R20-9-20241104","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/MCB.26.6.2093-2108.2006","article-title":"Normal cells, but not cancer cells, survive severe Plk1 depletion.","volume":"26","author":"Liu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R21-9-20241104","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.","volume":"17","author":"Steegmaier","year":"2007","journal-title":"Curr Biol"},{"key":"R22-9-20241104","first-page":"644","article-title":"Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.","volume":"9","author":"Strebhardt","year":"2010","journal-title":"Nat Rev"},{"key":"R23-9-20241104","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/sj.emboj.7600402","article-title":"Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.","volume":"23","author":"Pasini","year":"2004","journal-title":"EMBO J"},{"key":"R24-9-20241104","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.yexcr.2006.06.037","article-title":"ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.","volume":"312","author":"Kunapuli","year":"2006","journal-title":"Exp Cell Res"},{"key":"R25-9-20241104","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccr.2007.04.009","article-title":"Role of polycomb repressive complex 2 in acute promyelocytic leukemia.","volume":"11","author":"Villa","year":"2007","journal-title":"Cancer Cell"},{"key":"R26-9-20241104","doi-asserted-by":"crossref","first-page":"e3255","DOI":"10.1371\/journal.pone.0003255","article-title":"ZNF198 stabilizes the LSD-1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers.","volume":"3","author":"Gocke","year":"2008","journal-title":"PLoS ONE"},{"key":"R27-9-20241104","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.M109.077081","article-title":"Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells.","volume":"285","author":"Lu","year":"2010","journal-title":"J Biol Chem"},{"key":"R28-9-20241104","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1634\/stemcells.2006-0036","article-title":"The phenotypes of pluripotent human hepatic progenitors.","volume":"24","author":"Schmelzer","year":"2006","journal-title":"Stem Cells"},{"key":"R29-9-20241104","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor initiating cells with stemprogenitor cell features.","volume":"136","author":"Yamashita","year":"2009","journal-title":"Gastroenterology"},{"key":"R30-9-20241104","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/sj.onc.1206408","article-title":"ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A6B and RAD18 proteins.","volume":"22","author":"Kunapuli","year":"2003","journal-title":"Oncogene"},{"key":"R31-9-20241104","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/35036365","article-title":"The function of PML in p53-dependent apoptosis.","volume":"2","author":"Guo","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R32-9-20241104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1083\/jcb.200604009","article-title":"Promyelocyte leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR.","volume":"175","author":"Dellaire","year":"2006","journal-title":"J Cell Biol"},{"key":"R33-9-20241104","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1038\/sj.onc.1204759","article-title":"DNA viruses and viral proteins that interact with PML nuclear bodies.","volume":"20","author":"Everett","year":"2001","journal-title":"Oncogene"},{"key":"R34-9-20241104","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/JVI.01940-08","article-title":"The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by CoRESTRESTHDAC complex and degradation of PML, are executed in tandem.","volume":"83","author":"Gu","year":"2009","journal-title":"J Virol"},{"key":"R35-9-20241104","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1128\/JVI.02515-08","article-title":"Engagement of the lysine-specific demethylaseHDAC1CoRESTREST complex by herpes simplex virus 1.","volume":"83","author":"Gu","year":"2009","journal-title":"J Virol"},{"key":"R36-9-20241104","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1541-7786.MCR-09-0112","article-title":"PML NBs link the DNA damage repair pathway to hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.","volume":"7","author":"Chung","year":"2009","journal-title":"Mol Cancer Res"},{"key":"R37-9-20241104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4.","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"R38-9-20241104","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc Natl Acad U S A"},{"key":"R39-9-20241104","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1074\/jbc.274.4.2327","article-title":"Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines.","volume":"274","author":"Tarn","year":"1999","journal-title":"J Biol Chem"},{"key":"R40-9-20241104","first-page":"1715","article-title":"Antimicrob Agents C","volume":"41","author":"Ladner","year":"1997","journal-title":"hemother"},{"key":"R41-9-20241104","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1128\/JVI.02020-06","article-title":"Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo.","volume":"81","author":"Keasler","year":"2007","journal-title":"J Virol"},{"key":"R42-9-20241104","doi-asserted-by":"crossref","first-page":"25455","DOI":"10.1074\/jbc.M801934200","article-title":"Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis.","volume":"283","author":"Wang","year":"2008","journal-title":"J Biol Chem"},{"key":"R43-9-20241104","doi-asserted-by":"crossref","first-page":"36440","DOI":"10.1074\/jbc.C400300200","article-title":"Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.","volume":"279","author":"Rajendra","year":"2004","journal-title":"J Biol Chem"},{"key":"R44-9-20241104","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1097-2765(04)00062-0","article-title":"PML is a direct p53 target that modulates p53 effector functions.","volume":"13","author":"de Stanchina","year":"2004","journal-title":"Mol Cell"},{"key":"R45-9-20241104","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/MCB.26.5.1691-1699.2006","article-title":"Active role for Nibrin in the kinetics of Atm activation.","volume":"26","author":"Cerosaletti","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R46-9-20241104","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ccr.2008.09.001","article-title":"Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.","volume":"14","author":"Wang","year":"2008","journal-title":"Cancer Cell"},{"key":"R47-9-20241104","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(02)00626-8","article-title":"The role of PML in tumor suppression.","volume":"108","author":"Salomoni","year":"2002","journal-title":"Cell"},{"key":"R48-9-20241104","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1073\/pnas.95.16.9301","article-title":"Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk.","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R49-9-20241104","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng0198-84","article-title":"FGFR1 is fused with novel zinc-finger gene, ZNF198, in the t(8;13) leukaemialymphoma syndrome.","volume":"18","author":"Xiao","year":"1998","journal-title":"Nat Genet"},{"key":"R51-9-20241104","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjc.6602448","article-title":"Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological graderesults of an explorative CGH meta-analysis.","volume":"92","author":"Moinzadeh","year":"2005","journal-title":"Br J Cancer"},{"key":"R52-9-20241104","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/gcc.20247","article-title":"Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11.","volume":"44","author":"Chen","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"R53-9-20241104","doi-asserted-by":"crossref","first-page":"e1446","DOI":"10.1371\/journal.pone.0001446","article-title":"Lysine-specific demethylase 1 (LSD1) is required for transcriptional repression of the Telomerase Reverse Transcriptase (HTERT) gene.","volume":"3","author":"Zhu","year":"2008","journal-title":"PLoS ONE"},{"key":"R54-9-20241104","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1101\/gad.381706","article-title":"Genome-wide mapping of polycomb target genes unravels their roles in cell fate transitions.","volume":"20","author":"Bracken","year":"2006","journal-title":"Genes Dev"},{"key":"R55-9-20241104","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1128\/MCB.00204-08","article-title":"CTCF regulates allelic expression of Igf2 by orchestrating a promoteor-polycomb repressive complex 2 intrachromosomal loop.","volume":"28","author":"Li","year":"2008","journal-title":"Mol Cell Biol"},{"key":"R56-9-20241104","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-07-6013","article-title":"EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.","volume":"68","author":"Yamashita","year":"2008","journal-title":"Cancer Res"},{"key":"R59-9-20241104","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1158\/0008-5472.CAN-04-0292","article-title":"Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like-growth factor II overexpression.","volume":"64","author":"Breuhahn","year":"2004","journal-title":"Cancer Res"},{"key":"R60-9-20241104","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.","volume":"40","author":"Lee","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R61-9-20241104","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1128\/JVI.00068-10","article-title":"Polo-like kinase 1 is involved in hepatitis c virus replication by hyperphosphorylating NS5A.","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24163","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201104000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:03:50Z","timestamp":1730739830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201104000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24163","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}